B-Disease	0	5	Optic
I-Disease	6	14	neuritis
O	14	15	:
O	16	27	correlation
O	28	30	of
B-Symptom	31	35	pain
O	36	39	and
B-Diagnostic_tool	40	48	magnetic
I-Diagnostic_tool	49	58	resonance
I-Diagnostic_tool	59	66	imaging
O	66	67	.

O	69	71	To
O	72	83	demonstrate
O	84	91	whether
O	92	95	the
B-Diagnostic_tool	96	104	magnetic
I-Diagnostic_tool	105	114	resonance
I-Diagnostic_tool	115	122	imaging
O	123	124	(
B-Diagnostic_tool	124	127	MRI
O	127	128	)
O	129	141	localization
O	142	144	of
O	145	148	the
B-Symptom	149	157	abnormal
I-Symptom	158	169	enhancement
I-Symptom	170	172	of
I-Symptom	173	176	the
I-Symptom	177	182	optic
I-Symptom	183	188	nerve
O	189	192	can
O	193	195	be
O	196	203	related
O	204	206	to
O	207	210	the
B-Symptom	211	215	pain
O	216	218	or
O	219	226	pattern
O	227	229	of
B-Symptom	230	236	visual
I-Symptom	237	242	field
I-Symptom	243	247	loss
O	248	258	associated
O	259	263	with
B-Disease	264	269	acute
I-Disease	270	275	optic
I-Disease	276	284	neuritis
O	284	285	.

O	286	299	Retrospective
O	300	313	observational
O	314	320	series
O	321	324	and
B-Diagnostic_tool	325	328	MRI
O	329	335	review
O	336	340	from
O	341	342	a
O	343	351	referral
O	352	357	neuro
O	357	358	-
O	358	371	ophthalmology
O	372	379	service
O	379	380	.

O	381	388	Seventy
O	388	389	-
O	389	394	three
B-Characteristic	395	400	women
O	401	404	and
O	405	407	23
B-Characteristic	408	411	men
O	412	416	with
B-Disease	417	422	acute
I-Disease	423	428	optic
I-Disease	429	437	neuritis
O	438	441	who
O	442	445	had
B-Diagnostic_tool	446	450	high
I-Diagnostic_tool	451	461	resolution
I-Diagnostic_tool	462	472	gadolinium
I-Diagnostic_tool	472	473	-
I-Diagnostic_tool	473	481	enhanced
I-Diagnostic_tool	482	485	fat
I-Diagnostic_tool	485	486	-
I-Diagnostic_tool	486	496	suppressed
I-Diagnostic_tool	497	500	MRI
O	501	507	within
O	508	514	twenty
O	515	519	days
O	520	522	of
O	523	526	the
O	527	532	onset
O	533	535	of
B-Symptom	536	542	visual
I-Symptom	543	547	loss
O	547	548	.

O	549	552	The
O	553	561	presence
O	562	564	of
B-Symptom	565	568	eye
I-Symptom	569	571	or
I-Symptom	572	577	other
I-Symptom	578	583	fifth
I-Symptom	584	591	cranial
I-Symptom	592	597	nerve
I-Symptom	598	599	(
I-Symptom	599	600	V
I-Symptom	600	601	(
I-Symptom	601	602	1
I-Symptom	602	603	)
I-Symptom	603	604	)
I-Symptom	605	609	pain
O	609	610	,
O	611	614	and
B-Symptom	615	619	pain
I-Symptom	620	624	with
I-Symptom	625	628	eye
I-Symptom	629	637	movement
I-Symptom	638	649	ipsilateral
I-Symptom	650	652	to
I-Symptom	653	656	the
I-Symptom	657	665	affected
I-Symptom	666	671	optic
I-Symptom	672	677	nerve
O	678	680	or
B-Characteristic	681	683	no
I-Characteristic	684	687	eye
I-Characteristic	688	692	pain
O	693	696	was
O	697	705	recorded
O	705	706	.

O	707	710	The
O	711	727	neuroradiologist
O	728	736	reviewed
O	737	740	the
B-Diagnostic_tool	741	744	MRI
O	744	745	,
O	746	752	masked
O	753	755	to
O	756	759	the
O	760	768	affected
B-Anatomy	769	772	eye
O	772	773	,
O	774	777	and
O	778	786	recorded
O	787	790	the
B-Characteristic	791	797	length
I-Characteristic	798	801	and
I-Characteristic	802	809	segment
I-Characteristic	810	811	(
I-Characteristic	811	818	orbital
I-Characteristic	818	819	,
I-Characteristic	820	831	canalicular
I-Characteristic	831	832	,
I-Characteristic	833	845	intracranial
I-Characteristic	845	846	,
I-Characteristic	847	849	or
I-Characteristic	850	861	combination
I-Characteristic	862	864	of
I-Characteristic	865	873	segments
I-Characteristic	873	874	)
I-Characteristic	875	877	of
I-Characteristic	878	886	abnormal
I-Characteristic	887	892	optic
I-Characteristic	893	898	nerve
I-Characteristic	899	910	enhancement
O	910	911	.

O	912	915	The
O	916	926	presenting
B-Symptom	927	933	visual
I-Symptom	934	939	field
I-Symptom	940	947	defects
O	948	952	were
O	953	966	characterized
O	967	969	as
B-Characteristic	970	977	diffuse
I-Characteristic	977	978	,
I-Characteristic	979	986	central
I-Characteristic	986	987	,
I-Characteristic	988	995	arcuate
I-Characteristic	995	996	,
I-Characteristic	997	1002	nasal
I-Characteristic	1003	1005	or
I-Characteristic	1006	1014	temporal
O	1014	1015	.

O	1016	1019	The
O	1020	1025	types
O	1026	1028	of
B-Symptom	1029	1033	pain
O	1034	1037	and
O	1038	1046	patterns
O	1047	1049	of
B-Symptom	1050	1055	field
I-Symptom	1056	1060	loss
O	1061	1065	were
O	1066	1076	correlated
O	1077	1081	with
O	1082	1085	the
B-Characteristic	1086	1094	segments
I-Characteristic	1095	1097	of
I-Characteristic	1098	1103	optic
I-Characteristic	1104	1109	nerve
I-Characteristic	1110	1121	enhancement
O	1122	1124	in
O	1125	1128	the
O	1129	1137	affected
B-Anatomy	1138	1141	eye
O	1141	1142	.

O	1143	1147	Five
O	1148	1156	patients
O	1157	1160	had
B-Characteristic	1161	1167	nerves
I-Characteristic	1168	1172	that
I-Characteristic	1173	1176	did
I-Characteristic	1177	1180	not
I-Characteristic	1181	1188	enhance
O	1189	1192	and
O	1193	1197	were
O	1198	1206	excluded
O	1207	1211	from
O	1212	1215	the
O	1216	1223	outcome
O	1224	1232	analysis
O	1232	1233	.

O	1234	1236	In
O	1237	1240	the
O	1241	1243	91
O	1244	1252	patients
O	1253	1257	with
B-Symptom	1258	1266	abnormal
I-Symptom	1267	1278	enhancement
O	1278	1279	,
O	1280	1282	70
O	1283	1294	experienced
B-Symptom	1295	1298	eye
I-Symptom	1298	1299	/
I-Symptom	1299	1300	V
I-Symptom	1300	1301	(
I-Symptom	1301	1302	1
I-Symptom	1302	1303	)
I-Symptom	1304	1308	pain
O	1308	1309	,
O	1310	1312	67
O	1313	1316	had
B-Symptom	1317	1321	pain
I-Symptom	1322	1326	with
I-Symptom	1327	1330	eye
I-Symptom	1331	1339	movement
O	1340	1343	and
O	1344	1346	17
O	1347	1355	patients
O	1356	1359	had
B-Characteristic	1360	1362	no
I-Characteristic	1363	1367	pain
O	1367	1368	.

B-Symptom	1369	1380	Enhancement
I-Symptom	1381	1383	of
I-Symptom	1384	1387	the
I-Symptom	1388	1395	orbital
I-Symptom	1396	1401	optic
I-Symptom	1402	1407	nerve
O	1408	1416	occurred
O	1417	1419	in
O	1420	1422	66
O	1423	1431	patients
O	1431	1432	,
O	1433	1435	93
O	1435	1436	.
O	1436	1437	9
O	1437	1438	%
O	1439	1442	who
O	1443	1446	had
B-Symptom	1447	1450	eye
I-Symptom	1450	1451	/
I-Symptom	1451	1452	V
I-Symptom	1452	1453	(
I-Symptom	1453	1454	1
I-Symptom	1454	1455	)
I-Symptom	1456	1460	pain
O	1461	1464	and
O	1465	1467	92
O	1467	1468	.
O	1468	1469	4
O	1469	1470	%
O	1471	1474	who
O	1475	1478	had
B-Symptom	1479	1483	pain
I-Symptom	1484	1488	with
I-Symptom	1489	1492	eye
I-Symptom	1493	1501	movement
O	1501	1502	.

O	1503	1505	In
O	1506	1509	the
O	1510	1512	25
O	1513	1521	patients
O	1522	1526	with
B-Symptom	1527	1538	enhancement
I-Symptom	1539	1541	of
I-Symptom	1542	1545	the
I-Symptom	1546	1557	canalicular
I-Symptom	1557	1558	,
I-Symptom	1559	1571	intracranial
I-Symptom	1572	1574	or
I-Symptom	1575	1579	both
I-Symptom	1580	1588	segments
O	1588	1589	,
O	1590	1597	without
O	1598	1605	orbital
O	1606	1617	involvement
O	1617	1618	,
O	1619	1621	32
O	1621	1622	%
O	1623	1626	had
B-Symptom	1627	1630	eye
I-Symptom	1630	1631	/
I-Symptom	1631	1632	V
I-Symptom	1632	1633	(
I-Symptom	1633	1634	1
I-Symptom	1634	1635	)
I-Symptom	1636	1640	pain
O	1641	1644	and
O	1645	1647	24
O	1647	1648	%
O	1649	1652	had
B-Symptom	1653	1657	pain
I-Symptom	1658	1662	with
I-Symptom	1663	1666	eye
I-Symptom	1667	1675	movement
O	1675	1676	.

B-Characteristic	1677	1679	No
I-Characteristic	1680	1684	pain
O	1685	1693	occurred
O	1694	1696	in
O	1697	1698	3
O	1698	1699	%
O	1700	1704	with
B-Symptom	1705	1716	enhancement
I-Symptom	1717	1719	of
I-Symptom	1720	1723	the
I-Symptom	1724	1731	orbital
I-Symptom	1732	1739	segment
O	1740	1743	and
O	1744	1746	in
O	1747	1749	60
O	1749	1750	%
O	1751	1755	with
B-Symptom	1756	1767	enhancement
I-Symptom	1768	1770	of
I-Symptom	1771	1774	the
I-Symptom	1775	1780	other
I-Symptom	1781	1786	optic
I-Symptom	1787	1792	nerve
I-Symptom	1793	1801	segments
O	1801	1802	.

O	1803	1806	The
B-Characteristic	1807	1813	length
I-Characteristic	1814	1816	of
I-Characteristic	1817	1828	enhancement
O	1829	1839	moderately
O	1840	1850	correlated
O	1851	1855	with
B-Symptom	1856	1859	eye
I-Symptom	1859	1860	/
I-Symptom	1860	1861	V
I-Symptom	1861	1862	(
I-Symptom	1862	1863	1
I-Symptom	1863	1864	)
I-Symptom	1865	1869	pain
O	1870	1871	(
O	1871	1872	r
O	1873	1874	=
O	1875	1876	0
O	1876	1877	.
O	1877	1879	49
O	1879	1880	,
O	1881	1882	P
O	1883	1884	=
O	1885	1886	0
O	1886	1887	.
O	1887	1889	01
O	1889	1890	)
O	1891	1894	and
B-Symptom	1895	1899	pain
I-Symptom	1900	1904	with
I-Symptom	1905	1908	eye
I-Symptom	1909	1917	movement
O	1918	1919	(
O	1919	1920	r
O	1921	1922	=
O	1923	1924	0
O	1924	1925	.
O	1925	1927	37
O	1927	1928	,
O	1929	1930	P
O	1931	1932	=
O	1933	1934	0
O	1934	1935	.
O	1935	1937	01
O	1937	1938	)
O	1938	1939	.

O	1940	1948	Patients
O	1949	1953	with
B-Characteristic	1954	1965	enhancement
I-Characteristic	1966	1972	longer
I-Characteristic	1973	1977	than
I-Characteristic	1978	1980	10
I-Characteristic	1981	1983	mm
O	1984	1987	had
B-Symptom	1988	1992	pain
O	1993	1997	five
O	1998	2003	times
O	2004	2005	(
O	2005	2006	P
O	2007	2008	=
O	2009	2010	0
O	2010	2011	.
O	2011	2014	004
O	2014	2015	)
O	2016	2020	more
O	2021	2029	frequent
O	2030	2034	than
O	2035	2038	did
O	2039	2044	those
O	2045	2049	with
B-Characteristic	2050	2061	enhancement
I-Characteristic	2063	2064	<
I-Characteristic	2065	2067	or
I-Characteristic	2067	2068	=
I-Characteristic	2068	2070	10
I-Characteristic	2071	2073	mm
O	2073	2074	.

O	2075	2080	There
O	2081	2084	was
O	2085	2087	no
O	2088	2099	significant
O	2100	2108	specific
O	2109	2116	pattern
O	2117	2119	of
B-Symptom	2120	2125	field
I-Symptom	2126	2130	loss
O	2131	2141	associated
O	2142	2146	with
O	2147	2148	a
O	2149	2159	particular
B-Characteristic	2160	2168	location
I-Characteristic	2169	2171	of
I-Characteristic	2172	2183	enhancement
O	2183	2184	,
O	2185	2191	except
B-Symptom	2192	2200	temporal
I-Symptom	2201	2206	field
I-Symptom	2207	2211	loss
O	2212	2220	occurred
O	2221	2223	in
O	2224	2226	25
O	2226	2227	%
O	2228	2230	of
B-Symptom	2231	2243	intracranial
I-Symptom	2244	2251	lesions
O	2252	2253	(
O	2253	2254	P
O	2255	2256	=
O	2257	2258	0
O	2258	2259	.
O	2259	2261	04
O	2261	2262	)
O	2262	2263	.

O	2264	2268	When
B-Disease	2269	2274	optic
I-Disease	2275	2283	neuritis
O	2284	2292	involved
O	2293	2296	the
B-Characteristic	2297	2304	orbital
I-Characteristic	2305	2312	segment
I-Characteristic	2313	2315	of
I-Characteristic	2316	2319	the
I-Characteristic	2320	2325	optic
I-Characteristic	2326	2331	nerve
O	2331	2332	,
B-Symptom	2333	2336	eye
I-Symptom	2337	2339	or
I-Symptom	2340	2345	other
I-Symptom	2346	2347	V
I-Symptom	2347	2348	(
I-Symptom	2348	2349	1
I-Symptom	2349	2350	)
I-Symptom	2351	2363	distribution
I-Symptom	2364	2368	pain
O	2369	2370	(
O	2370	2372	94
O	2372	2373	.
O	2373	2374	3
O	2374	2375	%
O	2376	2378	vs
O	2378	2379	.
O	2380	2382	32
O	2382	2383	%
O	2383	2384	)
O	2385	2388	and
B-Symptom	2389	2393	pain
I-Symptom	2394	2398	with
I-Symptom	2399	2402	eye
I-Symptom	2403	2411	movement
O	2412	2413	(
O	2413	2415	91
O	2415	2416	.
O	2416	2417	4
O	2417	2418	%
O	2419	2421	vs
O	2421	2422	.
O	2423	2425	24
O	2425	2426	%
O	2426	2427	)
O	2428	2432	were
O	2433	2446	significantly
O	2447	2451	more
O	2452	2460	frequent
O	2460	2461	.

O	2462	2464	In
O	2465	2473	contrast
O	2473	2474	,
B-Symptom	2475	2479	pain
O	2480	2483	was
O	2484	2490	absent
O	2491	2493	20
O	2494	2499	times
O	2500	2504	more
O	2505	2510	often
O	2511	2515	when
O	2516	2519	the
B-Characteristic	2520	2527	orbital
I-Characteristic	2528	2535	segment
I-Characteristic	2536	2539	was
I-Characteristic	2540	2543	not
I-Characteristic	2544	2552	involved
O	2553	2554	(
O	2554	2556	60
O	2556	2557	%
O	2558	2560	vs
O	2560	2561	.
O	2562	2563	3
O	2563	2564	%
O	2564	2565	)
O	2565	2566	.

O	2567	2573	Except
O	2574	2577	for
B-Symptom	2578	2586	temporal
I-Symptom	2587	2592	field
I-Symptom	2593	2597	loss
I-Symptom	2598	2600	in
I-Symptom	2601	2605	eyes
I-Symptom	2606	2610	with
I-Symptom	2611	2623	intracranial
I-Symptom	2624	2629	nerve
I-Symptom	2630	2637	lesions
O	2637	2638	,
O	2639	2641	no
O	2642	2649	pattern
O	2650	2652	of
B-Symptom	2653	2659	visual
I-Symptom	2660	2665	field
I-Symptom	2666	2670	loss
O	2671	2679	appeared
O	2680	2682	to
O	2683	2692	correlate
O	2693	2697	with
O	2698	2701	the
B-Characteristic	2702	2710	location
I-Characteristic	2711	2713	or
I-Characteristic	2714	2720	length
I-Characteristic	2721	2723	of
I-Characteristic	2724	2732	abnormal
I-Characteristic	2733	2738	optic
I-Characteristic	2739	2744	nerve
I-Characteristic	2745	2756	enhancement
O	2756	2757	.
